Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Voyager Therapeutics Q4 2023 GAAP EPS $1.25 Beats $(0.29) Estimate, Sales $90.06M Beat $20.64M Estimate

Author: Benzinga Newsdesk | February 28, 2024 05:27pm
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $(0.29) by 531.03 percent. The company reported quarterly sales of $90.06 million which beat the analyst consensus estimate of $20.64 million by 336.44 percent. This is a 5.91K percent increase over sales of $(1.55 million) the same period last year.

Posted In: VYGR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist